Where Smart Money Is Going This Week: Deep Tech, AI Infrastructure, and the Rise of Strategic Co-Investment

This morning's venture funding roundup tells a story that every serious investor should be reading carefully.

PhysicsX, a London-based AI for hardware design company, raised $300 million led by Temasek. PointFive, a New York cloud cost management startup, raised $60 million led by Accel. A Security and InfoHawk closed tens of millions each to tackle AI-driven cybersecurity threats. Companion.energy and Rejuvenate Bio drew capital to solve energy and longevity challenges. Merck invested directly into Rejuvenate Bio alongside financial investors. Credit unions invested directly into Reset.

The pattern across today's deals is not subtle. Capital is flowing into startups that apply AI to industrial and enterprise problems, with large funds and strategic investors targeting sectors where AI can deliver clear, measurable ROI. Strategic relationships are evident throughout, with corporate investors participating as practical partners who provide distribution or validation in tough markets like healthcare and banking, not just as financial allocators.

This is the June 9, 2026 snapshot of where conviction capital is moving. And it tells you more about where the next decade of venture returns will come from than any trend report published last quarter.

The Three Themes Driving Today's Deals

Theme 1: AI for Hard Problems, Not Soft Ones

The deals being written right now are not going into AI wrappers on top of existing software. They are going into companies using AI to solve problems that were previously computationally impossible, economically unfeasible, or technically beyond what any team of humans could tackle at scale.

PhysicsX is the clearest example. Hardware design involves simulation workloads that have historically required weeks of compute and teams of specialized engineers. AI changes that equation fundamentally, compressing timelines and enabling design exploration that was never practical before. The $300 million check from Temasek is not a bet on AI as a category. It is a bet on a specific company that has crossed the threshold from interesting technology to production-grade infrastructure in a market with enormous economic value.

This pattern repeats across today's deals. PointFive is not a generic cloud management tool with AI bolted on. It is a company that uses machine learning to identify and eliminate cloud spend waste at a scale and speed that no manual process can replicate. The ROI case is immediate, specific, and large. That profile, AI solving a problem with clear economic value and no viable non-AI alternative, is what commands the largest checks in 2026.

The practical implication for investors: the question to ask of every AI deal is not "does this use AI?" It is "does this use AI to solve a problem that cannot be solved as well without it?" The first question returns hundreds of companies. The second returns a much smaller, much more defensible set.

Theme 2: Cybersecurity as an Evergreen Category

The funding flowing into A Security and InfoHawk this week is not an anomaly. It reflects a structural reality that investors have been underweighting relative to its importance.

AI has made cyberattacks faster, cheaper, and more sophisticated. Every enterprise deploying AI agents, every company building on foundation models, and every organization storing sensitive data in cloud environments is facing a threat surface that did not exist three years ago. The market for AI-native cybersecurity solutions is growing at a pace that makes most other enterprise software categories look slow.

The investment thesis is durable in ways that trend-driven categories are not. Cybersecurity spend is not discretionary. It does not get cut in a downturn. It grows when the threat environment grows, which in 2026 means it grows consistently. For investors building portfolios with resilience to macro cycles, cybersecurity remains one of the highest-conviction long positions in the market.

The specific opportunity in AI-native security is still early. Most of the incumbents, Palo Alto, CrowdStrike, SentinelOne, built their core platforms before the current generation of AI threats existed. The window for startups to build purpose-built AI security infrastructure is open now, before the incumbents have fully responded.

Theme 3: The Strategic Investor as Validation Signal

Today's deals feature something that is increasingly becoming a differentiating signal in early-stage diligence: strategic co-investors who bring distribution, not just capital.

Merck investing in Rejuvenate Bio alongside financial investors tells you something specific. It tells you that the product has been evaluated by people who understand the biology, the regulatory pathway, and the commercial landscape of the category at a level of depth that most generalist VCs cannot match. Strategic investors do not write checks into companies they are not willing to associate their brand with. Their participation is a form of due diligence that financial investors can leverage.

Credit unions investing in Reset carries the same signal in a different category. A consortium of financial institutions co-investing in a fintech startup is telling you that the product has survived scrutiny from the buyers themselves. That is a fundamentally different validation than a founder saying "our target customer is credit unions."

Strategic relationships are evident across today's June 9 deals, indicating that investors are seeking partners who provide distribution or validation in tough markets like healthcare and banking, not just financial returns. For investors evaluating whether to follow into a round, strategic co-investor participation should be weighted heavily in the diligence process. It is not a guarantee of success. It is a signal that the most informed buyers in the market have looked closely and decided to bet.

What the June 9 Deal Flow Tells You About the Broader Market

Today's deals are not a random sample. They are the visible tip of a pattern that has been building across the first half of 2026.

Q1 2026 saw the highest level of VC investment of any quarter on record, representing an all-time global high for the industry, with AI-related megadeals in the US as the primary driver. But the Q1 concentration in headline AI names is giving way to something more distributed and more interesting. Capital is beginning to flow into the second and third layers of the AI stack: the companies building the tooling, the infrastructure, the security, and the domain-specific applications that make the foundation models useful in the real world.

SVB's H1 2026 State of the Markets report describes the current environment as surgical: fewer deals, bigger checks, and conviction concentrated at the top. What today's deal flow shows is that the "top" is expanding beyond pure AI platform plays into adjacent sectors where AI creates genuine and defensible ROI. That expansion is where the most interesting early-stage opportunities are forming right now.

Healthcare, life sciences, climate tech, and industrial software keep pulling investor attention because they solve expensive problems with long-term demand. The deals written today into hardware design AI, cloud cost management, and longevity biotech are all expressions of this pattern. These are not hype categories. They are categories where the economic value of the solution is large, durable, and not easily competed away.

The Sectors Investors Are Watching Most Closely in June 2026

Based on the deal activity, funding patterns, and investor conversations defining this week, here are the categories commanding the most serious attention.

AI for industrial and engineering workflows. PhysicsX is the marquee example this week, but the category is broader. Simulation, design optimization, predictive maintenance, and quality control are all massive workflow categories where AI can compress timelines and reduce costs by orders of magnitude. The companies in this space have long sales cycles but high switching costs and multi-year contracts once embedded. The risk-adjusted return profile is attractive for investors with patience.

Cloud infrastructure efficiency. Every enterprise running AI workloads is experiencing compute cost pressure that is not going away. The companies that help organizations get more value from their existing cloud spend without requiring infrastructure overhaul are selling into a budget that exists, to a buyer who has already felt the pain. PointFive's round this week signals that institutional investors see this category as durable.

AI-native cybersecurity. Already discussed above but worth repeating: the threat surface is growing faster than incumbent defenses. The companies building purpose-built AI security tools are operating in a market where the customer urgency is high, the willingness to pay is established, and the competitive window against incumbents is still open.

Climate tech with clear ROI cases. Climate tech had a difficult 2024 and early 2025 as the category fell out of fashion with generalist investors. But the deals getting done now in climate are the ones with near-term commercial viability and clear unit economics. Companion.energy's round today reflects investor appetite for climate solutions that can demonstrate a return on 5 to 7 year timelines, not 15 to 20. The category is bifurcating between deep science bets and commercial climate software, and the commercial software bets are getting funded.

Longevity and healthspan biotech. Rejuvenate Bio and Goldenrod both raised this week in the longevity space. This category has been building credibility with institutional investors over the past 18 months as scientific progress has accelerated and the commercial pathway for longevity interventions has become clearer. Strategic investors like Merck participating in these rounds is the validation signal that the science is being taken seriously by the people most qualified to evaluate it.

How to Position Your Portfolio Around This Week's Signal

The deal flow of any given week is both a snapshot of current conviction and a leading indicator of where institutional attention will concentrate over the next 6 to 12 months. Here is how to act on what today's deals are telling you.

If you are deploying capital now: The categories that produced today's largest rounds, AI for hard industrial problems, AI-native security, and climate software with near-term ROI, are where the institutional consensus is forming. Getting ahead of that consensus, into earlier-stage companies in these categories before the competition for deals intensifies, is the highest-leverage deployment strategy available today.

If you are evaluating existing portfolio companies: Assess your current holdings against the themes driving today's deals. Do any of your portfolio companies sit at the intersection of AI and industrial workflows? Are any building infrastructure that benefits from the cloud cost pressure every enterprise is feeling? Are any positioned as AI-native security solutions? If yes, these are the companies that deserve your most active support in getting to the next milestone.

If you are thinking about co-investment: Today's deal pattern makes the case for strategic co-investment structures more clearly than any theoretical argument. The rounds that closed today were not solo investor deals. They were structured collaborations between financial investors and strategic partners who brought validation and distribution. Building your own co-investment practice, either as a lead who attracts strategic follow-on investors or as a follow-on investor who participates in strategically validated rounds, is the approach most aligned with how the best capital is being deployed right now.

If you are sourcing deals in emerging markets: The AI infrastructure and deep tech themes driving today's deals are not exclusively a US story. The same problems that PhysicsX is solving for hardware design, PointFive for cloud costs, and A Security for cybersecurity exist in every market where enterprises are deploying AI. The companies solving these problems in Africa, Southeast Asia, Latin America, and the Middle East are earlier stage, less competed for, and raising at valuations that reflect local market norms rather than Silicon Valley comparables. That combination is the definition of a risk-adjusted opportunity.

The Diligence Question That Separates This Week's Winners From the Rest

Every investor who passed on PhysicsX, PointFive, or today's other headline deals passed for a reason. Understanding what distinguishes the deals that attracted conviction from the ones that did not is more useful than celebrating the ones that closed.

The question that separates winning deals in 2026 from near-misses is this: is the AI solving a problem that could not be solved as well, as fast, or as cheaply without it?

This sounds simple. It is not. Most AI companies can generate a plausible answer to this question that sounds compelling in a pitch but does not hold up under scrutiny. The companies that generate a genuinely convincing answer are the ones where the AI creates a step-change in capability, not just a marginal efficiency improvement.

PhysicsX can run hardware simulations in hours that previously took weeks. That is a step-change. A company that uses AI to surface insights from data that a human analyst could surface more slowly is not a step-change. It is an efficiency improvement. Efficiency improvements attract attention. Step-changes attract $300 million checks.

Apply this test to every AI deal you evaluate this week. The companies that pass it are the ones worth competing for.

How SeedScope Keeps You Ahead of the Deal Flow

The gap between investors who see deals as they emerge and investors who see them after the institutional consensus has formed is the primary driver of return dispersion in early-stage venture.

Today's deals became today's deals because Temasek, Accel, and Lightspeed had been tracking these companies before they were widely known. The infrastructure they used to do that, proprietary sourcing networks, sector-specific scouts, and direct founder relationships built over years, is not accessible to most investors.

SeedScope is building that access layer for the investors who do not have a Temasek-sized research team. With active founders across 30+ countries, filtered by stage, sector, and geography, SeedScope surfaces the companies that are 12 to 24 months away from being in the deal flow that institutional investors compete for. AI-powered valuation benchmarking grounds every conversation in real market data rather than network intuition.

The companies that will define next week's deal roundup exist today. Some of them are on SeedScope right now.

Ready to find the deals before they become competitive? Explore active founders on SeedScope across 30+ countries. Start here →